A prospective, multicenter, randomized controlled study comparing the efficacy of empirical extended ablation and single-point ablation in the treatment of premature ventricular contractions

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055340

Enrollment

Unknown

Registered

2022-01-07

Start date

2021-10-01

Completion date

Unknown

Last updated

2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular premature beat

Interventions

Additional ablation group:Additional ablation

Focal ablation group:Focal ablation

Observation group:Common ablation

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with premature ventricular ablation for the first time; 2. There is a 24-hour dynamic electrocardiogram record before surgery; 3. Aged 18-75 years; 4. Willing to accept and cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. Have structural heart disease (dilated cardiomyopathy, old myocardial infarction, hypertrophic cardiomyopathy). 2. History of cardiac surgery. 3. Severe hepatic and renal insufficiency (AST or ALT > 3 times the upper limit; SCr > 3.5 mg/dl or Ccr < 30 ml/min). 4. Expected lifespan is less than 1 year. 5. Pregnant or lactating patients.

Design outcomes

Primary

Measure	Time frame
Ablation success rate;	—

Secondary

Measure	Time frame
Number of premature ventricular beats;Incidence of adverse events;	—

Countries

China

Contacts

Public ContactChen Minglong

The First Affiliated Hospital of Nanjing Medical University, Jiangsu Provincial People's Hospital

juweizhu@126.com+86 15358162522

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026